Carilion Clinic’s gynecologic oncology program conducts numerous, progressive research trials through its affiliations with the Gynecologic Oncology Group (GOG) and the National Cancer Institute (NCI). Research targeted to ovarian, cervical, uterine, and vulvar cancers provides specialized options for patients in all cancer stages.
In four years, the program has grown its research to conduct between 20-25 trials at any given time. Gynecologic oncologist Janet L. Osborne, M.D., leads the program’s research. Growth in the program has resulted in the hiring of a dedicated research staff. This additional workforce has allowed for an increased focus on patient quality and the ability to have a variety of research trials available.
The goal of these gyn-oncology trials is to supplement current medical care and to provide patients with new, innovative treatment options such as finding new drugs, or new uses for existing drugs, and exploring new surgical techniques.
Having the only board-certified gynecology oncology specialist in Southwest Virginia, Carilion Clinic’s gynecology oncology research program offers innovative treatment options to gynecologic cancer patients that aren’t available anywhere else in the valley. The research provides local access to cancer treatment that is cutting-edge and provides hope to patients and their families.